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IP3R (IP3 [inositol 1,4,5-trisphosphate] receptors) and ryanodine 
receptors are the most widely expressed intracellular Ca2 + 
channels and both are regulated by thiol reagents. In DT40 
cells stably expressing single subtypes of mammalian IP3R, 
low concentrations of thimerosal (also known as thiomersal), 
which oxidizes thiols to form a thiomercurylethyl complex, 
increased the sensitivity of IP3-evoked Ca2 +  release via IP3R1 
and IP3R2, but inhibited IP3R3. Activation of IP3R is initiated by 
IP3 binding to the IBC (IP3-binding core; residues 224–604) and 
proceeds via re-arrangement of an interface between the IBC and 
SD (suppressor domain; residues 1–223). Thimerosal (100 μM) 
stimulated IP3 binding to the isolated NT (N-terminal; residues 
1–604) of IP3R1 and IP3R2, but not to that of IP3R3. Binding 
of a competitive antagonist (heparin) or partial agonist (dimeric­
IP3) to NT1 was unaffected by thiomersal, suggesting that the 
effect of thimerosal is speciﬁcally related to IP3R activation. IP3 
binding to NT1 in which all cysteine residues were replaced by 
alanine was insensitive to thimerosal, so too were NT1 in which 
cysteine residues were replaced in either the SD or IBC. This 
demonstrates that thimerosal interacts directly with cysteine in 
both the SD and IBC. Chimaeric proteins in which the SD of 
the IP3R was replaced by the structurally related A domain of a 
ryanodine receptor were functional, but thimerosal inhibited both 
IP3 binding to the chimaeric NT and IP3-evoked Ca2 +  release 
from the chimaeric IP3R. This is the ﬁrst systematic analysis of 
the effects of a thiol reagent on each IP3R subtype. We conclude 
that thimerosal selectively sensitizes IP3R1 and IP3R2 to IP3 by 
modifying cysteine residues within both the SD and IBC and 
thereby stabilizing an active conformation of the receptor. 
Key words: Ca2 +  channel, IP3 receptor, IP3-binding core, redox 
regulation, ryanodine receptor, suppressor domain, thimerosal 
(thiomersal), thiol. 
INTRODUCTION 
IP3Rs [IP3 (inositol 1,4,5-trisphosphate) receptors] and RyRs 
(ryanodine receptors) are related families of intracellular Ca2 + 
channels (see Supplementary Figure S1 at http://www.biochemj. 
org/bj/451/bj4510177add.htm). IP3Rs are expressed in most 
animal cells [1] and RyRs are expressed in many cells, but 
most abundantly in excitable tissues [2]. Most IP3Rs and RyRs 
are expressed within the membranes of the endoplasmic or 
sarcoplasmic reticulum, where they mediate the release of Ca2 + 
stored within them. Vertebrate genomes have three genes for 
IP3R subunits and most have three genes for RyR. Functional 
intracellular Ca2 +  channels are tetrameric assemblies of these 
very large subunits, probably only homotetramers for RyR [2] (but 
see [3]), whereas IP3R form both homo- and hetero-tetrameric 
channels [1]. Activation of IP3R is initiated by binding of IP3 
to the IBC (IP3-binding core; residues 224–604) of each IP3R 
subunit [4] and then proceeds via re-arrangement of an interface 
between the IBC and SD (suppressor domain; residues 1–223) 
[5,6] (see Supplementary Figure S1). The links between these 
conformational changes within the NT (N-terminal residues 1– 
604) domains of the IP3R and gating of the channel formed 
by transmembrane helices close to the C-terminal are poorly 
understood, but they are known to require the SD [7]. 
The two families of intracellular Ca2 +  channels, IP3Rs and 
RyRs, share many characteristics including related structures [6], 
similar pores [8] and many aspects of their regulation. The latter 
includes regulation by cytosolic Ca2 +  [9,10] and modulation 
by thiol-reactive reagents [11,12]. Indeed, modiﬁcation of 
cysteinyl residues within ion channels is widespread [13–17], and 
contributes both to pathological responses to oxidative stress [18] 
and to physiological signals, including nitric oxide [19], hydrogen 
peroxide [20] and oxygen [21], which generate reactive oxygen 
or nitrogen species (see references in [22]). 
Thimerosal (also known as thiomersal) was once widely used 
as an antiseptic and as a preservative, particularly in childhood 
vaccines, but after considerable controversy it is now rarely used 
[23]. However, as a membrane-permeable thiol-oxidizing agent, 
thimerosal remains a useful experimental tool that interacts with 
free thiol groups to form a thiomercuryethyl complex. Many 
studies have reported thimerosal-evoked increases in cytosolic 
Ca2 +  concentration and suggested that they, at least partly, result 
from its effects, whether direct or via oxidation of GSH, on IP3Rs 
or RyRs (reviewed in [24]). 
Many thiol reagents, including thimerosal [25], biphasically 
regulate RyR activity: low concentrations stimulate activity, 
whereas higher concentrations are inhibitory [12,22]. This pattern 
is reminiscent of the biphasic regulation of RyR by cytosolic 
Ca2 +  [10], and consistent with evidence that oxidation of critical 
cysteine residues increases the sensitivity of RyRs to endogenous 
regulators [26] (reviewed in [12]). There are approximately 100 
cysteine residues in each RyR subunit and within the reducing 
Abbreviations used: CLM, cytosol-like medium; GST, glutathione transferase; IBC, inositol 1,4,5-trisphosphate-binding core; IP3, inositol 1,4,5­
trisphosphate; IP3R, inositol 1,4,5-trisphosphate receptor; Kd, equilibrium dissociation constant; KO, knockout; NT, N-terminal; NT1CL, cysteine-less 
NT1; NT1CL − IBC, NT1 where cysteine residues within the IBC were replaced by alanine; NT1CL − SD, NT1 where cysteine residues within the SD were 
replaced by alanine; RyR, ryanodine receptor; RyR1A, A domain of the type 1 RyR; RyR2A, A domain of the type 2 RyR; SD, suppressor domain. 
1 These authors contributed equally to this work. 
2 To whom correspondence should be addressed (email cwt1000@cam.ac.uk). 
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environment of the cytosol approximately half of these are in 
the reduced state [22]. A few of these residues are particularly 
susceptible to oxidation, and their susceptibility depends on 
whether the RyR is open or closed. But there is not yet any 
clearly deﬁned relationship between oxidation of speciﬁc cysteine 
residues and channel activity (reviewed in [12]). 
An abundant amount of evidence demonstrates that IP3R 
activity is also modulated by thiol-oxidizing agents [27] (reviewed 
in [11]). In many cells, for example, the effects of thimerosal on 
IP3-evoked Ca2 +  release are rather similar to its biphasic effects 
on RyRs: potentiation of responses at low concentrations and 
inhibition of Ca2 +  release at higher concentrations of thimerosal 
[11]. Although the responses to thimerosal in intact cells are 
undoubtedly made more complicated by its effects on additional 
Ca2 + -handing proteins and perturbation of GSH/GSSG [28], there 
are clearly direct biphasic effects on IP3R behaviour [29] (see 
references in [11]). There are 60 cysteine residues in each IP3R1 
subunit and most are likely to be in the reduced form in their 
native setting [11]. None of the 12 cysteine residues within the S1 
splice variant of the IP3R1 NT are required for effective gating 
of IP3Rs by IP3 [6], but two conserved cysteine residues within 
the C-terminal tail (Cys2610 and Cys2613) are essential [7], and 
three reduced cysteine residues within the third luminal loop of 
IP3R1 (Cys2496, Cys2504 and Cys2527) are essential for its redox-
sensitive interaction with a luminal thioredoxin-related protein, 
ERp44 [30]. The mechanisms whereby thimerosal or other thiol 
reagents modulate IP3R behaviour have not been resolved, but 
they are relevant to understanding redox regulation of IP3Rs under 
physiological and pathological conditions, and to deﬁning further 
the mechanisms of IP3R activation. The mechanism by which 
thimerosal regulates the three subtypes of IP3Rs is addressed in 
the present study. 
MATERIALS AND METHODS 
Materials 
Thimerosal and heparin (sodium salt from bovine intestinal 
mucosa) were from Sigma–Aldrich. IP3 was from Enzo Life 
Sciences (Exeter). [3H]IP3 (18 Ci/mmol) was from PerkinElmer 
Life and Analytical Sciences. Dimeric IP3 (structure shown 
in Figure 3A) was synthesized and characterized as reported 
previously [5]. Sources of other materials are speciﬁed in previous 
publications [31,32] or within the relevant methods sections. 
Expression of NT fragments of IP3 receptors 
NT fragments of rat IP3R1 (NT1 and IBC) (Supplementary 
Table S1 at http://www.biochemj.org/bj/451/bj4510177add.htm) 
were ampliﬁed by PCR from the full-length coding sequence of 
IP3R1 lacking the S1 splice site (GenBank accession number: 
GQ233032.1) and ligated into pGEX-6P-2 vectors (GE Health-
care). The open reading frame encoding NT2 (residues 1–604 
from mouse IP3R2) (GenBank: GU980658.1) and NT3 (residues 
1–604 from rat IP3R3) (GenBank: GQ233031.1) were ampliﬁed 
by PCR using the primers listed in Supplementary Table S2 
(at http://www.biochemj.org/bj/451/bj4510177add.htm). PCR 
products were digested with SmaI and XhoI and ligated into 
pGEX-6P-2 vectors for expression in Escherichia coli. The 
methods used to express an NT1CL (cysteine-less NT1) in which all 
endogenous cysteine residues of the NT of IP3R1 were replaced by 
alanine, and a chimaeric NT (RyR2A-IBC) in which the A domain 
of the type 2 RyR (RyR2; residues 1–210) (GenBank: GI164831) 
[33] was fused to the IBC of rat IP3R1 were described recently [6]. 
The plasmid encoding NT1CL − IBC (NT1 where cysteine residues 
within the IBC were replaced by alanine) (Supplementary Table 
S1) was generated from the NT1 construct using QuikChange 
multi-site-directed mutagenesis (Agilent). The NT1CL construct 
was used as the template to prepare a plasmid encoding NT1CL − SD 
(NT1 where all endogenous cysteine residues within the SD were 
replaced by alanine) (Supplementary Table S1). The sequence 
encoding the cysteine-less SD was PCR-ampliﬁed from the NT1CL 
template using the primers listed in Supplementary Table S2. PCR 
products were then ligated into the pET41a( + ) vector containing 
the open reading frame of the IBC of IP3R1 as SpeI/EcoRV 
fragments for expression in E. coli. The coding sequences of 
all expression constructs were conﬁrmed. Supplementary Table 
S1 lists the proteins used and their abbreviations. 
All N-terminal fragments of IP3R were expressed 
as fusion proteins linked to N-terminal GST (gluta­
thione transferase) via a PreScission cleavage site in 
E. coli BL21 (DE3) exactly as described previously 
[32]. Bacteria were harvested (6000 g for 15 min at 
4 ◦C), washed twice with phosphate-buffered saline and stored 
at − 80 ◦C before puriﬁcation of the fragments. Bacterial pellets 
were suspended (1 g/10 ml) in Tris-buffered medium [50 mM 
Tris and 1 mM EDTA (pH 8.3)] and lysed by incubation 
with 100 μg/ml lysozyme (Sigma–Aldrich), 5 units/ml DNase 
(Sigma–Aldrich) and 10 μg/ml RNase (Sigma–Aldrich) for 1 h on 
ice, followed by sonication (30 s). After centrifugation (30 000 g 
for 60 min at 4 ◦C), the supernatant was mixed with glutathione– 
Sepharose 4B beads [GE Healthcare; lysate/beads (v/v) 50:1) and 
incubated with gentle rotation for 1 h at 20 ◦C. The beads were 
then washed with Tris-buffered medium supplemented with 1 mM 
dithiothreitol, centrifuged (500 g for 5 min at 4 ◦C) and incubated 
in the same medium (1 ml) supplemented with 160 units/ml GST-
tagged PreScission protease (GE Healthcare) for 16 h at 4 ◦C 
with gentle rotation. After centrifugation (500 g for 5 min at 
4 ◦C), the NT fragments, cleaved from their GST tags, were 
recovered in the supernatant and rapidly frozen in liquid nitrogen 
before storage at − 80 ◦C. Immunoblots of the proteins used 
are shown in Supplementary Figure S3 (at http://www.biochemj. 
org/bj/451/bj4510177add.htm). 
[3H]IP3 binding 
Equilibrium competition binding assays were performed in 
Tris-buffered medium (500 μl) containing puriﬁed protein (1– 
5 μg), [3H]IP3 (0.25–0.75 nM) and appropriate concentrations of 
competing ligand. Where indicated, thimerosal was added 10 min 
before the addition of [3H]IP3. Reactions were terminated after 
5 min by addition of poly(ethylene glycol)-8000 [Sigma–Aldrich; 
30 % (w/v) 500 μl] and γ -globulin (Sigma–Aldrich; 750 μg in  
30 μl of Tris-buffered medium). Bound and free [3H]IP3 were 
then separated by centrifugation (20000 g for 5 min). Results 
were ﬁtted to Hill equations using GraphPad Prism (version 
5.0, GraphPad) from which IC50, and thereby Kd (equilibrium 
dissociation constant) and pKd, values were calculated. 
Ca2 + release from the intracellular stores of DT40 cells expressing 
IP3R subtypes 
DT40 cells, in which the genes for all three endogenous IP3R 
subtypes had been disrupted [DT40-KO (knockout) cells], were 
used to generate stable cell lines expressing rat IP3R1, mouse 
IP3R2 or rat IP3R3 (DT40-IP3R1–3 cells) or a chimaeric IP3R 
(RyR1A-IP3R1) in which the SD of IP3R1 was replaced by 
the equivalent A domain of rabbit type 1 RyR (RyR1; residues 
 
c© The Authors Journal compilation c© 2013 Biochemical Society© 2013 The Author(s) 
The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Licence (CC-BY)(http://creativecommons.org/licenses/by/3.0/)
which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
Non-Commercial Licence (http://creativec mmons.org/licenses/by-nc/2.5/)
non-commercial use, distrib tion a d reproduction in any medium, provided the original work is properly cited. 
179 Subtype-selective regulation of IP3R by thimerosal 
1 – 210; GenBank accession number: X15209) (DT40-RyR1A­
IP3R1 cells) (Supplementary Table S1). The methods used to 
establish these stable cell lines have been described previously 
[6,34]. All DT40 cells were grown in suspension at 37 ◦C 
in an atmosphere of 95 % air and 5 % CO2 in RPMI 1640 
medium supplemented with 2 mM L-glutamine, 10 % fetal 
bovine serum, 1 % heat-inactivated chicken serum and 50 μM 
2-mercaptoethanol. Cells were used or passaged when they 
reached a density of ∼2×106 cells/ml. Expression levels of 
IP3Rs in the cell lines were compared by immunoblotting using 
antisera selective for each IP3R subtype or an anti-peptide serum 
(AbC) that interacts equally with all three IP3R subtypes. The 
immunoblotting methods were reported previously [34]. 
A low-afﬁnity Ca2 +  indicator, Mag-ﬂuo-4, trapped within the 
endoplasmic reticulum, was used to measure luminal free Ca2 + 
concentration [31]. The endoplasmic reticulum of DT40 cells 
(∼4×106 cells/ml) was loaded with indicator by incubating 
cells in the dark (for 1 h at 20 ◦C) with 20 μM Mag-ﬂuo-4/AM 
(acetoxymethyl ester) in Hepes-buffered saline [135 mM NaCl, 
5.9  mM KCl, 11.6  mM Hepes, 1.5  mM  CaCl2, 11.5 mM glucose 
and 1.2 mM MgCl2 (pH 7.3)], supplemented with Pluronic F127 
(1 mg/ml) and BSA (0.4 mg/ml). After centrifugation (650 g for 
2 min), cells (∼4×106 cells/ml) were suspended in Ca2 + -free 
CLM [cytosol-like medium; 140 mM KCl, 20 mM NaCl, 2 mM 
MgCl2, 1 mM EGTA and 20 mM Pipes (pH 7.0)], supplemented 
with saponin (ﬁnal concentration 20 μg/ml) to allow for selective 
permeabilization of the plasma membrane. After ∼4 min  at  37  ◦C, 
when all cells had become permeable to 0.1 % Trypan Blue, 
the cells (5×105 cells/ml) were recovered (650 g for 2 min) and 
suspended at 20 ◦C in Mg2 + -free CLM, supplemented with CaCl2 
(375 μM, to provide a ﬁnal free Ca2 +  concentration of 220 nM 
after addition of 1.5 mM MgATP) and 10 μM FCCP (carbonyl cy­
anide p-triﬂuoromethoxyphenylhydrazone). The cells were then 
distributed into poly-L-lysine-coated 96-well plates (50 μl/well), 
centrifuged (300 g for 2 min) and used for ﬂuorescence 
measurements. Fluorescence (excitation 485 nm, emission 
520 nm, measured at 1.5 s intervals) was recorded at 20 ◦C using  
a FlexStation III plate-reader (Molecular Devices) [31]. MgATP 
(1.5 mM) was added to allow intracellular stores to sequester 
Ca2 + . After the stores had loaded to steady state (∼150 s), IP3 was 
added with thapsigargin (1 μM to inhibit Ca2 + re-uptake). Ca2 + 
release was measured after a further 60 s. The Ca2 + release evoked 
by IP3 is expressed as a fraction of the ATP-dependent Ca2 + uptake 
[31]. Concentration–effect relationships were ﬁtted to Hill equa­
tions using non-linear curve ﬁtting (version 5.0, GraphPad Prism). 
Statistical analyses of IP3R sensitivity to IP3 used pEC50 
and pKd values (negative logarithm of the EC50 and Kd 
respectively). Results are presented as means + S.E.M. For−
clarity, mean EC50 and Kd values (derived from pEC50 or 
pKd) are shown alongside. In paired comparisons of the 
effects of thimerosal, pEC50 (or pKd) values are shown, 
where pEC50 = EC50thimerosal − pEC50control. Statistical analyses 
used ANOVA followed by paired Student’s t test. P < 0.05 was 
considered signiﬁcant. 
RESULTS AND DISCUSSION 
Thimerosal potentiates IP3-evoked Ca2 + release via IP3R1 and 
IP3R2 
In DT40 cells stably expressing only IP3R1 (DT40-IP3R1 cells) 
(Figure 1A), IP3 caused a concentration-dependent release of 
Ca2 + from intracellular stores (pEC50 = 7.95 + 0.04) (Figure 1B).−
Pre-incubation with thimerosal (10 μM for 120 s) increased the 
sensitivity to IP3 (pEC50 = 8.95 + 0.31, pEC50 = 1.00 + 0.32)− −
Figure 1 IP3-evoked Ca2 + release via IP3R1 and IP3R2 is sensitized by 
thimerosal 
(A) Immunoblot (4×104 cells/lane) using an antiserum (AbC) that recognizes a conserved NT 
sequence in all IP3R subtypes demonstrates that expression levels of the three IP3R subtypes and 
chimaeric IP3R are broadly similar in each of the four cell lines. There are no detectable IP3Rs in 
the DT40-KO cells. (B–D) Concentration-dependent effects of IP3 on Ca2 + release are shown 
for control cells and after treatment with thimerosal (10 μM, 2 min) for DT40 cells expressing 
each of the three IP3R subtypes. Results are means + S.E.M. for at least three independent−
experiments. The structure of thimerosal is shown within (B). �, control; �, thimerosal. 
without affecting loading of the Ca2 +  stores or the maximal 
response to IP3 (Table 1 and Figure 1B). Similar results were 
obtained with DT40 cells expressing only IP3R2 (DT40-IP3R2 
cells) (Figure 1A), where 10 μM thimerosal also increased the 
sensitivity to IP3 (pEC50 = 0.60 + 0.20) (Figure 1C). For both−
IP3R1 and IP3R2, higher concentrations of thimerosal inhibited 
responses to IP3 (Table 1). However, in DT40 cells expressing 
IP3R3 (DT40-IP3R3 cells) (Figure 1A), 10 μM thimerosal 
inhibited IP3-evoked Ca2 +  release (pEC50 = − 0.17 + 0.01)−(Figure 1D), without signiﬁcantly affecting loading of the 
intracellular Ca2 +  stores (Table 1). The latter demonstrates that 
the diminished responses to IP3 were not due to thimerosal 
activating IP3R3 and thereby draining the Ca2 +  stores before 
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Table 1 Effects of thimerosal on IP3-evoked Ca2 + release by different IP3Rs 
DT40 cells expressing each of the IP3R subtypes were incubated with the indicated concentrations of thimerosal during loading of the intracellular stores with Ca2 +  (2 min) before addition of IP3. 
Results show Ca2 +  uptake (as a percentage of its value in the absence of thimerosal), maximal IP3-evoked Ca2 +  release (as a percentage of the Ca2 +  content of the stores before addition of IP3) 
and the Hill coefﬁcient (h), pEC50 and EC50 values for the IP3-evoked Ca2 +  release. All results (except EC50, which shows only the mean, see the Materials and methods section) are shown as 
means +− S.E.M. for three to four independent experiments. ND, not determined. 
IP3R subtypes Thimerosal (μM) Ca2 +  uptake (%) EC50 (nM) pEC50 h Maximal Ca2 +  release (%) 
IP3R1 0 
1 
10 
100 
100 
98 +− 5 
97 +− 7 
93 +− 6 
11 
7 
1 
77 
7.95 +− 0.04 
8.16 +− 0.13 
8.95 +− 0.31* 
7.11 +− 0.18* 
2.0 +− 0.1 
1.2 +− 0.2 
2.7 +− 0.8 
1.0 +− 0.4 
84 +− 2 
89 +− 1* 
85 +− 2 
42 +− 11* 
IP3R2 0 
1 
10 
100 
100 
99 +− 2 
96 +− 7 
93 +− 3 
23 
14 
6 
35 
7.64 +− 0.01 
7.87 +− 0.22 
8.24 +− 0.26* 
7.46 +− 0.28 
1.6 +− 0.1 
1.3 +− 0.2 
2.2 +− 0.3 
0.9 +− 0.2 
74 +− 2 
78 +− 3 
77 +− 4 
67 +− 2* 
IP3R3 0 
1 
10 
100 
100 
99 +− 3 
97 +− 8 
86 +− 6 
576 
687 
860 
2185 
6.24 +− 0.04 
6.16 +− 0.08 
6.07 +− 0.06* 
5.66 +− 0.02* 
1.2 +− 0.1 
1.0 +− 0.1 
1.3 +− 0.1 
3.0 +− 0.5 
88 +− 2 
90 +− 5 
78 +− 8 
54 +− 2* 
RyR1A-IP3R1 0 
1 
10 
100 
100 
97 +− 4 
89 +− 4 
66 +− 8* 
65 
78 
238 
ND 
7.19 +− 0.01 
7.11 +− 0.04 
6.62 +− 0.18* 
ND 
2.4 +− 0.1 
2.0 +− 0.2 
1.6 +− 0.2 
ND 
81 +− 4 
76 +− 3 
80 +− 6 
12 +− 1 = 
*P < 0.05 relative to its control. =Response to 1 μM IP3. 
addition of IP3. Functional effects of thimerosal were reported 
previously for DT40 cells expressing IP3R1 or IP3R3 [29], but 
use of the same single sub-threshold concentration of IP3 for 
both IP3R subtypes when IP3R3 is much less sensitive to IP3 
(Figure 1 and Table 1) [35] compromised the conclusion that 
thimerosal sensitizes only IP3R1. Our results, demonstrating that 
low concentrations of thimerosal sensitize IP3R1 and IP3R2 
to IP3 while inhibiting IP3R3, are consistent with previous 
studies in which thimerosal [29,36–42] or other thiol reagents 
[40,43,44] potentiated IP3-evoked Ca2 +  signals in cells expressing 
predominantly IP3R1 [29,37,42] or IP3R2 [38,40,43,44], but not 
in cells where IP3R3 predominates [29,39,41]. We conclude 
that within homotetrameric populations of IP3R, thimerosal 
potentiates responses from IP3R1 and IP3R2, but inhibits 
IP3R3. 
Thimerosal stimulates IP3 binding to the NTs of IP3R1 and IP3R2 
Thimerosal stimulates IP3-evoked Ca2 +  release via puriﬁed IP3R1 
[37] and it stimulates [3H]IP3 binding to puriﬁed IP3R1 [37] and 
its isolated NT [29]. This conﬁrms that thimerosal directly affects 
IP3R1. Activation of IP3R is initiated by IP3 binding to the IBC and 
proceeds via re-arrangement of interactions between the IBC 
and SD [6]. We therefore examined [3H]IP3 binding to the NTs 
of IP3R1–IP3R3, a region that comprises the critical SD and IBC 
(Supplementary Figure S1A). 
Incubation (10 min) of puriﬁed NT from IP3R1 (NT1) with 
thimerosal caused a concentration-dependent stimulation of 
[3H]IP3 binding that was maximal with 100 μM thimerosal 
and then reversed at higher concentrations (Figure 2A). A 
biphasic effect of thimerosal on [3H]IP3 binding to full-length 
IP3R1  [45]  and an NT region of IP3R1 (residues 1–581) was 
reported previously [46]. The maximally effective concentration 
of thimerosal (100 μM) caused a 12-fold increase in the afﬁnity of 
NT1 for IP3 (pKd 1.07 += − 0.28) (Figure 2B and Table 2). 
The effect of maximally effective concentrations of thimerosal 
(10–100 μM) on the sensitivities of functional responses of 
IP3R1 to IP3 (pEC50 = 1.00 + binding to NT1− 0.32) and IP3 (pKd = − 0.28) are similar: both are increased ∼10­1.07 +
fold. The results were similar with IP3R2: 100 μM thimerosal 
caused a ∼10-fold increase in the afﬁnity of NT2 for IP3 
(pKd = − 0.19) (Figure 2C and Table 2). There was no1.05 +
signiﬁcant effect of thimerosal on IP3 binding to the NT of IP3R3 
(Figure 2D and Table 2). 
Previous work suggested that thimerosal stimulates [3H]IP3 
binding to full-length IP3R1, but not to IP3R3, whereas it 
stimulated binding to the NT region (residues 1–581) of IP3R1 
and IP3R3, but not to that of IP3R2 [29,46]. The previous 
conclusions are neither internally consistent nor consistent with 
our observations using NT1–NT3 (residues 1–604) (Figure 2). 
The residues missing in the shorter NT fragments are reasonably 
conserved between IP3R subtypes and they lack cysteine residues 
(Supplementary Figure S1B). However, from the high-resolution 
structure of the IBC [4], an NT region truncated at residue 581 
is likely to disrupt an α-helix (α9 in [4]), the NT of which 
forms essential interactions with IP3. Furthermore, the published 
afﬁnities for IP3 of these shorter fragments from IP3R1 and IP3R3 
are indistinguishable, which is inconsistent with evidence that in 
both NT and full-length proteins, IP3R3 has lower afﬁnity than 
IP3R1 [35] (Table 2). It seems likely that the shorter fragments 
used in the previous studies [29,46] may not retain the native 
structure of the IBC. 
Our results with [3H]IP3 binding to the NT from all three 
IP3R subtypes (Figure 2), evidence from [3H]IP3 binding to 
full-length IP3R1 and IP3R3 expressed in Sf9 insect cells [29], 
our functional analyses of DT40 cells expressing homogenous 
populations of IP3R subtypes (Figure 1) and substantial evidence 
from native cells expressing different IP3R subtypes (discussed 
above) are consistent with the conclusion that low concentrations 
of thimerosal stimulate IP3 binding and IP3-evoked Ca2 +  release 
via IP3R1 and IP3R2, but not via IP3R3. These observations 
support the hypothesis that cysteine residues within the NT of 
IP3R1 and IP3R2 mediate the sensitizing effects of thimerosal on 
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Figure 2 Thimerosal stimulates [3H]IP3 binding to the NT of IP3R1 and 
IP3R2 
(A) Speciﬁc binding of [3H]IP3 (0.5 nM) to the NT of IP3R1 is shown after pre-incubation (10 min) 
with the indicated concentrations of thimerosal. Results are shown as the percentage of speciﬁc 
[3H]IP3 binding measured in the absence of thimerosal. (B–D) Concentration-dependent effects 
of IP3 on speciﬁc [3H]IP3 binding (0.5 nM) to the NT from each of the three IP3R subtypes alone 
or after incubation with thimerosal (100 μM, 10 min). (A–D) Results are means +− S.E.M. for 
four independent experiments. �, control; �, thimerosal. 
IP3-evoked Ca2 +  release. Subsequent experiments address this 
hypothesis. 
Thimerosal stimulates agonist, but not antagonist, binding to the 
NT of IP3R1 
Heparin is a competitive antagonist of IP3R [47], and dimeric IP3 
(see Figure 3A for structure) is a high-afﬁnity partial agonist: 
the IP3 dimer binds to the IP3R, but causes lesser activation 
than IP3 such that the channel opens less frequently [5]. Both 
heparin and IP3 dimer completely displaced speciﬁcally bound 
[3H]IP3 from NT1, but thimerosal (100 μM, 10 min) affected the 
afﬁnity of neither: pKd was 0.11 + − 0.19 for− 0.09 and − 0.06 +
heparin and IP3 dimer respectively (Figure 3 and Table 3). These 
Table 2 Effects of thimerosal on [3H]IP3 binding to the NT of each IP3R 
subtype 
Equilibrium-competition binding experiments using [3H]IP3 (0.5 nM) and NT1–NT3 show the 
effects of thimerosal (100 μM, 10 min) on the K d (mean), pK d − S.E.M.) and Hill(mean +
coefﬁcient (h, mean +− S.E.M.) for IP3. pK d = pK dthimerosal − pK dcontrol . Results are from at 
least four independent experiments. 
pK d (K d; nM)  h 
NT subtype Control Thimerosal pKd 
NT1 
NT2 
NT3 
8.62 +− 0.10 
(2.39) 
1.2 +− 0.2 
9.12 +− 0.07 
(0.76) 
0.6 +− 0.04 
8.06 +− 0.06 
(8.72) 
0.7 +− 0.06 
9.69 +− 0.26∗ 
(0.20) 
1.2 +− 0.3 
10.17 +− 0.15∗ 
(0.07) 
0.6 +− 0.02 
7.91 +− 0.17 
(12.4) 
1.0 +− 0.05 
1.07 +− 0.28 
1.05 +− 0.19 
0.15 +− 0.22 
*P < 0.05 relative to its control. 
Figure 3 Thimerosal does not affect binding of an antagonist or partial 
agonist 
(A and B) Concentration-dependent effects of the IP3 dimer (A) or heparin  (B) on speciﬁc [3H]IP3 
binding (0.25 nM) to the NT from IP3R1 alone or after incubation with thimerosal (100 μM, 
10 min). Results are means +− S.E.M. for four independent experiments. The structure of the IP3 
dimer is shown within (A). �, control; �, thimerosal. 
results are important because they demonstrate that thimerosal 
selectively affects the binding of ligands that activate IP3R. It is, 
however, noteworthy that thimerosal alone does not activate IP3R. 
Concentrations of thimerosal (�10 μM) that cause substantial 
sensitization of IP3R1 and IP3R2 do not affect the Ca2 +  content 
of the stores in the absence of IP3 (Table 1). These results suggest 
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Table 3 Effects of thimerosal on binding of heparin and IP3 dimer to the NT 
from IP3R1 
Equilibrium-competition binding experiments using [3H]IP3 (0.25 nM) and NT1 show the effects 
of thimerosal (100 μM, 10 min) on the K d (mean), pK d (mean +− S.E.M.) and Hill coefﬁcient (h, 
mean +− S.E.M.) for IP3 dimer and heparin. pK d = pK dthimerosal − pK dcontrol . Results are from �four independent experiments. 
pK d (K d) h 
Control Thimerosal pK d 
IP3 dimer 
Heparin 
9.81 +− 0.07 
(0.15 nM) 
1.2 +− 0.1 
7.06 +− 0.09 
(87 ng/ml) 
0.82 +− 0.17 
9.75 +− 0.14 
(0.18 nM) 
1.7 +− 0.4 
7.17 +− 0.03 
(68 ng/ml) 
0.73 +− 0.09 
− 0.06 +− 0.19 
0.11 +− 0.09 
that thimerosal might selectively stabilize an agonist-bound active 
conformation of IP3R1. 
Cysteine residues within both the SD and IBC are required for 
thimerosal to stimulate IP3 binding 
Previous work demonstrated that thimerosal stimulates [3H]IP3 
binding to NT1, but not to the IBC [29]. Results shown in 
Figure 4 conﬁrm that conclusion. We have shown that NT1CL is 
structurally and functionally indistinguishable from native NT1 
[6]. The lack of effect of thimerosal on [3H]IP3 binding to NT1CL 
(Figure 4A) conﬁrms that cysteine residues mediate its effects. 
We had anticipated, in keeping with earlier evidence [29], that 
cysteine residues within the SD were likely to mediate the effects 
of thimerosal. However, thimerosal had no effect on [3H]IP3 
binding to NT lacking cysteine in either the SD (NT1CL − SD) or the  
IBC (NT1CL − IBC) (Figures 4B and 4C). These results demonstrate 
that stimulation of IP3 binding by thimerosal requires cysteine 
residues within both the SD and IBC. 
Residues within the NT are required for thimerosal to potentiate 
IP3-evoked Ca2 + release 
It would be instructive to examine the functional effects of 
thimerosal on full-length IP3R1 in which cysteine residues within 
the NT are replaced by alanine and so verify whether the NT 
mediates the effects of thimerosal on IP3-evoked Ca2 +  release. 
We have demonstrated that IP3R1 with a cysteine-less NT is 
functional, but only in transiently transfected DT40-KO cells [6], 
in which it is impracticable to complete the concentration–effect 
relationships needed to deﬁne the effects of thimerosal. We have 
not yet succeeded in establishing stable DT40 cell lines expressing 
IP3R1 with a cysteine-less NT. We therefore adopted another 
approach and used a stable DT40 cell line expressing a chimaeric 
IP3R1 in which the native SD is replaced by the equivalent region 
(the A domain) from a RyR (RyR1A-IP3R1) [6] (Figure 5A, and 
Supplementary Table S1). 
The A domain of RyR, which is structurally similar to the 
SD of IP3R [6,48–50] (Supplementary Figure S1C and S1D), 
can functionally replace the SD of IP3R1 to allow both IP3­
evoked Ca2 +  release from a chimaeric IP3R and appropriate 
regulation of IP3 binding to a chimaeric NT [6]. All effective 
concentrations of thimerosal (1 μM–1 mM) inhibited [3H]IP3 
binding to the chimaeric NT (RyR2A-IBC) (Figures 5A and 5B), 
although the effect appeared biphasic. Thimerosal (10 μM, 2 min) 
Figure 4 Stimulation of IP3 binding by thimerosal requires cysteine 
residues within the SD and IBC 
(A) Effects of thimerosal (100 μM, 10 min) on speciﬁc binding of [3H]IP3 (0.5 nM) to each of 
the indicated proteins. Results are expressed as a percentage of the binding measured in the 
absence of thimerosal. (B and C) Concentration-dependent effects of thimerosal on speciﬁc 
[3H]IP3 binding to NT1CL − SD (B) and NT1CL − IBC (C). All results are means +− S.E.M. for four 
independent experiments. 
also inhibited IP3-evoked Ca2 +  release from the chimaeric IP3R 
(RyR1A-IP3R1) (Figure 5C and Table 1). These results suggest 
that these cysteine residues present within the SD of IP3R1, but 
absent from the A domain of RyR, are required for thimerosal to 
potentiate IP3-evoked Ca2 +  release. 
Conclusions 
Thimerosal potentiates IP3-evoked Ca2 +  release via IP3R1 and 
IP3R2, but not via IP3R3 (Figure 1). The parallel behaviour of NTs 
from each of the three IP3R subtypes (Figure 2), our demonstration 
that cysteine residues are required within both the IBC and SD 
for thimerosal to stimulate IP3 binding (Figure 4) and evidence 
that thimerosal does not potentiate responses from a chimaeric 
IP3R1 in which the SD is replaced by the equivalent domain 
of a RyR (Figure 5) provide persuasive evidence that cysteine 
residues within the SD and IBC mediate functional responses 
to thimerosal. Furthermore, thimerosal selectively stimulates 
agonist, but not antagonist, binding to NT1 (Figure 3), suggesting 
that its interactions with critical cysteine residues selectively 
stabilize an active conformation of the NT. Because IP3 binding re­
arranges interactions between the SD and IBC [6], this conclusion 
aligns with a previous suggestion that thimerosal stabilizes an 
interaction between the IBC and SD of IP3R1 [29]. 
We do not know which speciﬁc cysteine residues are modiﬁed 
by thimerosal. Despite its subtype-selective actions (Figures 1 
and 2) and evidence that sensitization by thimerosal is mediated 
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Figure 5 A chimaeric IP3R1 is not stimulated by thimerosal 
(A) The proteins used. (B) Concentration-dependent effects of thimerosal on speciﬁc [3H]IP3 (0.5 nM) binding to RyR2A-IBC. Results are expressed as percentages of the binding measured in the 
absence of thimerosal. (C) Concentration-dependent effects of IP3 on Ca2 +  release from DT40-RyR1A-IP3R1 cells are shown for control cells and after treatment with thimerosal (10 μM, 2 min). 
Results in (B and C) are means +− S.E.M. from four independent experiments. 
by cysteine residues within the NT, we have been unable 
to identify candidate cysteine residues from sequence data 
alone (see legend to Supplementary Figure S2 at http://www. 
biochemj.org/bj/451/bj4510177add.htm). Preliminary MALDI­
TOF (matrix-assisted laser desorption ionization–time-of-ﬂight) 
analyses were uninstructive, and it is impracticable to assay NT 
in which every pair of cysteine residues are mutated. It is perhaps 
surprising that cysteine residues in both the SD and IBC are 
required for thimerosal to sensitize IP3R1. This requirement is 
unlikely to result from cross-linking of a pair of cysteine residues 
by thimerosal because available evidence suggests that thimerosal 
forms a mercuryethyl adduct with a single cysteine [24]. An 
alternative possibility is that thimerosal disrupts a disulﬁde bridge 
between cysteine residues in the SD and IBC that constrains IP3R 
activation. This too seems unlikely. There is no evidence from the 
high-resolution structure of the NT for such a disulﬁde bridge [6]. 
Furthermore, IP3R with cysteine-less NT are not constitutively 
active and respond normally to IP3 [6]. We also used algorithms 
that predict the accessibility [51] and reactivity [52] of cysteine 
residues together with modelled structures of NT2–NT3 [53] to 
identify cysteine residues that might account for the differential 
sensitivities of IP3R1–IP3R3 to thimerosal. The results suggest 
that within the SD, there are two accessible cysteine residues 
(Cys206 and Cys214 in IP3R1) and they are predicted to be equally 
accessible in all three subtypes, but the residue equivalent to Cys214 
in IP3R1 is less reactive in IP3R3 (Supplementary Figure S2). 
Within the IBC, Cys556 is predicted to be accessible in IP3R1 
and IP3R2, but it is buried in IP3R3. Cys214 in the SD and Cys556 
in the IBC of IP3R1 therefore have the properties expected to 
explain the sensitization of IP3R1 and IP3R2, but not IP3R3, by 
thimerosal. Further experimental work would be needed to assess 
this directly. We have provided the ﬁrst systematic analysis of the 
effects of thiol reagents on each IP3R subtype. We conclude that 
thimerosal sensitizes IP3R1 and IP3R2, but not IP3R3, to IP3. It  
does so by modifying cysteine residues within both the SD and 
IBC and thereby stabilizing an active conformation of the IP3R. 
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Subtype-selective regulation of IP3 receptors by thimerosal via cysteine 
residues within the IP3-binding core and suppressor domain 
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Table S1 Proteins used and their abbreviations 
Abbreviations Protein 
IP3R1 Full-length rat IP3R1 lacking S1 splice region (GenBank: GQ233032.1) 
IP3R2 Full-length mouse IP3R2 (GenBank: GU980658.1) 
IP3R3 Full-length rat IP3R3 (GenBank: GQ233031.1) 
RyR1A-IP3R1 Full-length rat IP3R1 (GenBank: GQ233032.1) with residues 1–224 replaced by residues 1–210 from rabbit RyR1 (GenBank: X15209) 
NT1 Residues 1–604 from rat IP3 R1 
NT2 Residues 1–604 from mouse IP3 R2 
NT3 Residues 1–604 from rat IP3 R3 
IBC Residues 224–604 from rat IP3R1 
NT1CL Residues 1–604 from rat IP3 R1 with all cysteine residues replaced by alanine 
NT1CL − SD Residues 1–604 from rat IP3 R1 with all cysteine residues within the SD (residues 1–223) replaced by alanine 
NT1CL − IBC Residues 1–604 from rat IP3 R1 with all cysteine residues within the IBC (residues 224–604) replaced by alanine 
RyR2A-IBC Residues 1–604 from rat IP3 R1 with residues 1-224 replaced by residues 1–210 from rabbit RyR2 (GenBank: GI164831) 
Table S2 Primers used 
Sequences of the forward (F) and reverse (R) primers used to amplify by PCR the sequences encoding the constructs used. Other primers have been speciﬁed in earlier publications [1,2]. 
Construct Direction Sequence (5′–3′) 
NT2 
NT3 
NT1CL − SD 
F 
R 
F 
R 
F 
R 
GGCCCCCGGGATGTCTGACAAAATGTCCAGCTTCCTCTACATTGGG 
GGCCCTCGAGTTATTTGCGGTTGTTGTGTAACAAGGCTGTAATCGT 
GGCCCCCGGGATGAATGAAATGTCCAGCTTTCTTCACATCGGGGAC 
GGCCCTCGAGTTACTTCCGGTTGTTGTGCAGCAGGGC CGTGATGGT 
ACTAGTATGTCTGACAAAATGTCTAGTTTCCT 
GATATCGAAAAGCACTATTTTCCAGCTTG 
1 These authors contributed equally to this work.

2 To whom correspondence should be addressed (email cwt1000@cam.ac.uk).
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S. A. Khan and others 
Figure S1 Comparison of key sequences between IP3R subtypes and RyR 
(A) Key domains of a single subunit of rat IP3R1 and rabbit RyR1 shown to highlight locations of the SD and A domain. (B) Sequence alignment (Clustal) of the three IP3R subtypes. Cyan shows the 
SD and green shows the IBC. Red arrowheads highlight cysteine residues that differ between IP3R subtypes. (C) Sequence alignment (Clustal) of the SD of the three IP3R subtypes and A domains of 
RyR1 and RyR2. (D) Structural alignments (Pymol) of the SD of IP3R1 (cyan; PDB 1XZZ) and A domain of RyR2 (grey; PDB 3IM5). 
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Subtype-selective regulation of IP3R by thimerosal 
Figure S2 Differences in the accessibility and reactivity of cysteine residues within the NT of IP3R subtypes may account for their differential regulation by 
thimerosal 
(A–C) Structural homology models [3] of NT2 and NT3 on the basis of the known structure of NT1CL (PDB 3UJ4) [2] with the native cysteine restored (using Pymol). The structures show the SD 
(cyan) and IBC (green) and the positions of all cysteine residues. Thimerosal increases the sensitivity to IP3 of IP3R1 and IP3R2, but not of IP3R3 (Figure 1 of the main text), and its actions require 
cysteine residues within the NT (Figures 4 and 5 of the main text). We therefore considered whether residues conserved within the SD and IBC of IP3R1 and IP3R2, but absent from IP3R3, might be 
responsible. There are six cysteine residues within the SD of IP3R1, two of these (Cys56 and Cys61) are not required for thimerosal to stimulate IP3 binding [4], and ﬁve of the residues are conserved 
in all three IP3R subtypes. The remaining cysteine residue (Cys15) is unique to IP3R1. The IBC of the IP3R1 used in the present study (where the S1 splice site, which includes Cys326, is removed) 
has six cysteine residues, four of which are conserved, but the remaining two (Cys530 and Cys553) are unique to IP3R1. There are therefore no cysteine residues in the NT that are uniquely conserved 
in IP3R1 and IP3R2. Replacing the SD of IP3R1 with the A domain of RyR1 caused thimerosal to become inhibitory, suggesting that cysteine residues present in the SD, but absent from the A domain, 
might contribute to the stimulatory effect of thimerosal. Two of the six cysteine residues within the SD (Cys36 and Cys56) are conserved in all three IP3R subtypes, RyR1 and RyR2, and are therefore 
unlikely to mediate stimulation of IP3R1 by thimerosal. None of the remaining four cysteine residues in the SD are present in the A domain, but neither are they uniquely shared with IP3R2. We were 
therefore unable to identify from these sequence comparisons alone the cysteine residues within the NT that are likely to mediate the stimulatory effect of thimerosal. The reactivity of a cysteine 
residue depends on its accessibility and whether it is deprotonated [5,6]. Using the NT1–NT3 structures, two cysteine residues were identiﬁed that would be expected to be reactive in NT1 and NT2, 
but non-reactive in NT3. These residues are highlighted (grey) in the structures and their surface accessibility is shown in the right-hand panels. 
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Figure S3 Expression of NT fragments of IP3R 
Immunoblots of the indicated puriﬁed fragments (3 μg/lane), using AbC, which recognizes a 
sequence conserved in all IP3R subtypes (residues 240–253 of rat IP3R1). Molecular mass 
markers are shown on the left in kDa. 
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